CD4+ T cells from SLE patients and lupus‐prone animals show increased mitochondrial metabolism and glycolysis, suggesting that SLE patients experience altered intrinsic metabolism reprogramming [279]. The gene discussed is CD4; the disease is systemic lupus erythematosus.